The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 20, 2017
Filed:
Jan. 04, 2013
Applicants:
Interna Technologies B.v., Nijmegen, NL;
Koninlijke Nederlandse Akademie Van Wetenschappen, Amsterdam, NL;
Inventors:
Eugene Berezikov, Haren, NL;
Jos Bernard Poell, Utrecht, NL;
Willemijn Maria Gommans, Voorschoten, NL;
Rick Jan van Haastert, Amersfoort, NL;
Andreas Alphons F. L. van Puijenbroek, Boxtel, NL;
Roeland Quirinus Jozef Schaapveld, Bussum, NL;
Gregoire Pierre Andre Prevost, Antony, FR;
Assignee:
INTERNA TECHNOLOGIES B.V., Amsterdam, NL;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C12N 15/11 (2006.01); C12Q 1/68 (2006.01); A61K 31/7088 (2006.01); C12N 15/113 (2010.01);
U.S. Cl.
CPC ...
A61K 31/7088 (2013.01); C12N 15/111 (2013.01); C12N 15/113 (2013.01); C12N 15/1135 (2013.01); C12Q 1/6809 (2013.01); C12N 2310/113 (2013.01); C12N 2310/141 (2013.01); C12N 2320/10 (2013.01); C12N 2320/31 (2013.01); C12N 2330/10 (2013.01);
Abstract
The invention relates to the diagnostic and therapeutic uses of a miRNA molecule, an equivalent or a source thereof in a disease and condition associated with melanoma or a disease or a condition associated with activated BRAF pathway.